| Literature DB >> 35836562 |
Kajal Modi1, Ramanujam Padmapriya1, Subashini Elango1, Priyal Khandelwal1, Buvaneshwari Arul1, Velmurugan Natanasabapathy1.
Abstract
The objective of the study is to describe the clinical and radiographic features of nonmalignant nonendodontic periapical lesions (NMNPLs) mimicking lesions of endodontic cause. Five electronic databases, PubMed, Web of Science, Scopus, Embase, and ProQuest, were searched (till July 2021) for case reports, case series, and cross-sectional studies, in English language, reporting NMNPLs, which were clinically and/or radiographically simulating periapical pathosis of endodontic origin. Data extraction was done followed by quality assessment of the included articles using the Joanna Briggs Institute tool for case reports and case series. Seventy-three articles comprising 176 cases were included. Sixty-one articles were case reports, nine articles were case series, and three articles were retrospective studies. Male:female ratio was 1.5:1, with a higher prevalence of lesions occurring in the fourth and second decades of life. The majority of the lesions were located in the anterior maxilla. Radiographically, most of the lesions were well defined, radiolucent, and unilocular. Histologically, 29 different types of NMNPLs were reported, with the most common ones being odontogenic keratocyst (25.56%), dentigerous cyst (17.61%), ameloblastoma (11.36%), nasopalatine duct cyst (10.79%), and adenomatoid odontogenic tumor (5.68%). As all the included studies were observational, the quality of available evidence is considered low. Various features such as loss of tooth vitality, history of trauma, and presence of periapical radiolucency may lead to misdiagnosis of NMNPLs and must be considered during diagnosis of the lesion. Additional imaging modalities and histopathology can aid in right diagnosis. Copyright:Entities:
Keywords: Diagnostic error; misdiagnosis; nonendodontic lesion; nonmalignant lesion; periapical disease; periapical lesion
Year: 2022 PMID: 35836562 PMCID: PMC9274689 DOI: 10.4103/jcd.jcd_13_22
Source DB: PubMed Journal: J Conserv Dent ISSN: 0972-0707
Search strategy
| Database | Search strategy |
|---|---|
| PubMed | (“Periapical diseases”[MeSH] OR periapical patho* OR apical periodontitis OR periapical granuloma OR radicular cyst OR periapical cyst OR endodontic periapical lesion OR periapical abscess OR dentoalveolar abscess) AND (benign lesion OR benign patho* OR benign tumor OR non endodontic lesion OR non odontogenic OR odontogenic cyst) AND (“diagnostic errors”[MeSH] OR “diagnosis, differential/diagnosis”[MeSH] OR mimic*) |
| Scopus | TITLE-ABS-KEY (“periapical disease” OR “periapical patho*” OR “apical periodontitis” OR “periapical granuloma” OR “radicular cyst” OR “periapical cyst” OR “endodontic periapical lesion” OR “periapical abscess” OR “dentoalveolar abscess”) AND (“benign lesion” OR “benign pathosis” OR “benign tumor” OR “non endodontic lesion” OR “non endodontic lesion” OR “non odontogenic” OR “odontogenic cyst”) AND (“diagnostic error” OR “differential diagnosis” OR “mimic*”) |
| Embase, Web of Science, ProQuest | (Periapical diseases OR periapical pathosis OR apical periodontitis OR periapical granuloma OR radicular cyst OR periapical cyst OR endodontic periapical lesion OR periapical abscess OR dentoalveolar abscess) AND (benign lesion OR benign pathosis OR benign tumor OR non endodontic lesion OR non odontogenic OR odontogenic cyst) AND (diagnostic errors OR differential diagnosis OR mimic) |
Figure 1Literature search flow diagram
Excluded articles and cases with reasons
| Author, year | Reason for exclusion |
|---|---|
| Neville, 1996 | Full text article not available |
| Kuc, 2000 | Radiographic features not mentioned |
| Cases excluded from case series | Radicular cyst mimicking odontogenic cyst (cases 1 and 2); cancer metastasis (case 5) |
Figure 2Pie charts representing prevalence of (a) gender, (b) age, and (c) site of the lesions. These results do not include the age, gender, and site of one retrospective study Kosanwat et al., 2021
Figure 3Nonmalignant nonendodontic periapical lesions and their frequency
Results of the included articles
| Variable | |
|---|---|
| Geographic region ( | |
| Asia | 117 (66.47) |
| South America | 23 (13.06) |
| North America | 22 (12.5) |
| Europe | 12 (6.81) |
| Australia | 2 (1.13) |
| Appearance ( | |
| Radiolucent | 167 (94.88) |
| Mixed | 8 (4.5) |
| Radiopaque | 1 (0.56) |
| Borders ( | |
| Ill defined | 5 (3.67 ) |
| Well defined | 131 (96.32) |
| Pattern ( | |
| Unilocular | 126 (90.64) |
| Multilocular | 13 (9.35) |
| Symptoms ( | |
| Symptomatic | 80 (78.43) |
| Asymptomatic | 22 (21.56) |
| Bone ( | |
| Perforation | 21 (52.5) |
| Expansion | 12 (30) |
| Expansion+perforation | 2 (5) |
| No | 5 (12.5) |
| Root resorption ( | |
| Yes | 17 (50) |
| No | 17 (50) |
| Pulp sensibility ( | |
| Normal response | 21 (38.18) |
| No response | 21 (38.18) |
| Combination of normal and no response | 7 (12.72) |
| Previously root canal initiated/treated | 5 (9.09) |
| Inconclusive | 1 (1.81) |
| Case reports | 61 cases |
| Case series | 9 articles; 24 cases |
| Retrospective studies | 3 articles; 95 cases |
| Total | 73 articles; 176 cases |
Data extraction of the included articles
|
|
Preferred reporting items for systematic reviews and meta-analysis checklist 2020
| Section and topic | Item# | Checklist item | Location where item is reported |
|---|---|---|---|
| Title | |||
| Title | 1 | Identify the report as a systematic review | 0 |
| Abstract | |||
| Abstract | 2 | See the PRISMA 2020 for Abstracts checklist | 1 and 2 |
| Introduction | |||
| Rationale | 3 | Describe the rationale for the review in the context of existing knowledge | 3 and 4 |
| Objectives | 4 | Provide an explicit statement of the objective(s) or question(s) the review addresses | 3 and 4 |
| Methods | |||
| Eligibility criteria | 5 | Specify the inclusion and exclusion criteria for the review and how studies were grouped for the syntheses | 4 |
| Information sources | 6 | Specify all databases, registers, websites, organizations, reference lists, and other sources searched or consulted to identify studies. Specify the date when each source was last searched or consulted | 5 |
| Search strategy | 7 | Present the full search strategies for all databases, registers and websites, including any filters and limits used | 5 and |
| Selection process | 8 | Specify the methods used to decide whether a study met the inclusion criteria of the review, including how many reviewers screened each record and each report retrieved, whether they worked independently, and if applicable, details of automation tools used in the process | 5, 32 |
| Data collection process | 9 | Specify the methods used to collect data from reports, including how many reviewers collected data from each report, whether they worked independently, any processes for obtaining or confirming data from study investigators, and if applicable, details of automation tools used in the process | 5 |
| Data items | 10a | List and define all outcomes for which data were sought. Specify whether all results that were compatible with each outcome domain in each study were sought (e.g., for all measures, time points, analyses), and if not, the methods used to decide which results to collect | 5 |
| 10b | List and define all other variables for which data were sought (e.g., participant and intervention characteristics, funding sources). Describe any assumptions made about any missing or unclear information | 5 | |
| Study risk of bias assessment | 11 | Specify the methods used to assess risk of bias in the included studies, including details of the tool(s) used, how many reviewers assessed each study and whether they worked independently, and if applicable, details of automation tools used in the process | 6 |
| Effect measures | 12 | Specify for each outcome the effect measure(s) (e.g., risk ratio, mean difference) used in the synthesis or presentation of results | - |
| Synthesis methods | 13a | Describe the processes used to decide which studies were eligible for each synthesis (e.g., tabulating the study intervention characteristics and comparing against the planned groups for each synthesis (item #5)) | 4, 5 |
| 13b | Describe any methods required to prepare the data for presentation or synthesis, such as handling of missing summary statistics, or data conversions | 5 | |
| 13c | Describe any methods used to tabulate or visually display results of individual studies and syntheses | 5 | |
| 13d | Describe any methods used to synthesize results and provide a rationale for the choice(s). If meta-analysis was performed, describe the model(s), method(s) to identify the presence and extent of statistical heterogeneity, and software package(s) used | - | |
| 13e | Describe any methods used to explore possible causes of heterogeneity among study results (e.g., subgroup analysis, meta-regression) | - | |
| 13f | Describe any sensitivity analyses conducted to assess robustness of the synthesized results | - | |
| Reporting bias assessment | 14 | Describe any methods used to assess risk of bias due to missing results in a synthesis (arising from reporting biases) | - |
| Certainty assessment | 15 | Describe any methods used to assess certainty (or confidence) in the body of evidence for an outcome | - |
| Results | |||
| Study selection | 16a | Describe the results of the search and selection process, from the number of records identified in the search to the number of studies included in the review, ideally using a flow diagram | 6, 32 |
| 16b | Cite studies that might appear to meet the inclusion criteria, but which were excluded, and explain why they were excluded | 6 and | |
| Study characteristics | 17 | Cite each included study and present its characteristics | 7 |
| Risk of bias in studies | 18 | Present assessments of risk of bias for each included study | 8, 33, 34 |
| Results of individual studies | 19 | For all outcomes, present, for each study: (a) summary statistics for each group (where appropriate) and (b) an effect estimate and its precision (e.g., confidence/credible interval), ideally using structured tables or plots | 7, 8, 30, 31, 35, 36, |
| Results of syntheses | 20a | For each synthesis, briefly summarize the characteristics and risk of bias among contributing studies | 7, 8, 30, 31 |
| 20b | Present results of all statistical syntheses conducted. If meta-analysis was done, present for each the summary estimate and its precision (e.g., confidence/credible interval) and measures of statistical heterogeneity. If comparing groups, describe the direction of the effect | - | |
| 20c | Present results of all investigations of possible causes of heterogeneity among study results | - | |
| 20d | Present results of all sensitivity analyses conducted to assess the robustness of the synthesized results | - | |
| Reporting biases | 21 | Present assessments of risk of bias due to missing results (arising from reporting biases) for each synthesis assessed | - |
| Certainty of evidence | 22 | Present assessments of certainty (or confidence) in the body of evidence for each outcome assessed | - |
| Discussion | |||
| Discussion | 23a | Provide a general interpretation of the results in the context of other evidence | 9-16 |
| 23b | Discuss any limitations of the evidence included in the review | 9, 16 | |
| 23c | Discuss any limitations of the review processes used | 16 | |
| 23d | Discuss implications of the results for practice, policy, and future research | 15, 16, 37 | |
| Other information | |||
| Registration and protocol | 24a | Provide registration information for the review, including register name and registration number, or state that the review was not registered | 17 |
| 24b | Indicate where the review protocol can be accessed, or state that a protocol was not prepared | 17 | |
| 24c | Describe and explain any amendments to information provided at registration or in the protocol | - | |
| Support | 25 | Describe sources of financial or non-financial support for the review, and the role of the funders or sponsors in the review | 17 |
| Competing interests | 26 | Declare any competing interests of review authors | 17 |
| Availability of data, code and other materials | 27 | Report which of the following are publicly available and where they can be found: template data collection forms; data extracted from included studies; data used for all analyses; analytic code; any other materials used in the review | - |
Source.[121] For more information, visit: http://www.prisma-statement.org/. PRISMA: Preferred reporting items for systematic reviews and meta-analysis
Figure 4Graphical representation of scientific merit assessment of included articles using the Joanna Briggs Institute tool: (a) case reports; (b) case series. Green indicates “low risk of bias,” yellow indicates “some risk of bias,” and red indicates “high risk of bias”
Figure 5Scientific merit assessment scoring of individual articles using the Joanna Briggs Institute tool: (a-i and a-ii) case reports; (b) case series. “+” indicates yes, “−” indicates no, and “?” indicates unclear response
Figure 6Guideline for diagnosis of periapical lesions